BHYLOR
"BHYLOR" is a word mark owned by Mineralys Therapeutics, Inc., filed at the USPTO on March 31, 2025. It has been allowed and covers class 5 (Pharmaceuticals).
- Status
- Allowed
- Since March 25, 2026
- Filed
- March 31, 2025
- Registered
- Not yet
- Expires
- Not recorded
- Application no.
- 99112415
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns BHYLOR
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Mineralys Therapeutics, Inc.
MLYS · Radnor, United States
Representative
Holly Pekowsky
Amster, Rothstein & Ebenstein LLP
What the mark covers
The products and services BHYLOR is filed for, grouped by Nice class.
Pharmaceutical preparations for the prevention and treatment of hypertension, sleep apnea, chronic kidney disease, heart failure, primary aldosteronism, myocardial infarction, coronary artery disease, blood vessel wall thickening, renal fibrosis, nephropathy, and vascular dementia
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of approval of extension request e-mailed
- Sou extension 1 granted
- Sou extension 1 filed
- Sou teas extension received
- Noa e-mailed - sou required from applicant
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
10 earlier steps on the official record.
About BHYLOR
Who owns the trademark "BHYLOR"?
The USPTO trademark "BHYLOR" (application 99112415) is owned by Mineralys Therapeutics, Inc.
What is the status of "BHYLOR"?
Its status at the USPTO is: allowed.
Get this data via the API
Everything on this page comes from the Signa API. Pull BHYLOR and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2a9e-5b15-771c-a167-91fabb8706af
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2a9e-5b15-771c-a167-91fabb8706af",
"object": "trademark",
"mark_text": "BHYLOR",
"status": {
"primary": "pending",
"stage": "allowed"
},
"office_code": "US",
"application_number": "99112415",
"filing_date": "2025-03-31",
"nice_classes": [
5
],
"owners": [
{
"name": "Mineralys Therapeutics, Inc.",
"entity_id": "ent_019eb715-ae85-763e-9335-c439bf7a261b"
}
]
}